Empresa Biotech Acquisition Company Nasdaq
Acciones
BIOTU
KYG1125A1242
Holding Companies
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Michael Shleifer
CEO | Chief Executive Officer | 49 | - |
Thomas Fratacci
DFI | Director of Finance/CFO | 46 | 01/09/20 |
Ivan Jarry
COO | Chief Operating Officer | 45 | 01/09/20 |
Albert F. Hummel
CIO | Chief Investment Officer | 78 | 01/09/20 |
Tanguy Serra
PRN | Corporate Officer/Principal | 45 | 03/09/20 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Albert F. Hummel
CIO | Chief Investment Officer | 78 | 01/09/20 |
Bruno Montanari
BRD | Director/Board Member | 49 | 25/01/21 |
Paul D. Bernard
BRD | Director/Board Member | 55 | 25/01/21 |
Michael Shleifer
CEO | Chief Executive Officer | 49 | - |
Aaron Kim
BRD | Director/Board Member | 53 | 25/01/21 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 5 750 000 | 0 | 0 | 80,00 % |
Acción B | 1 | 23 000 000 | 23 000 000 ( 100,00 %) | 0 |
Información de la empresa
Varia. 1 de ene. | Capi. | |
---|---|---|
+2,67 % | 987 M | |
+49,30 % | 961 M | |
+2,49 % | 668 M | |
-.--% | 600 M | |
-2,15 % | 582 M | |
+10,28 % | 536 M | |
-.--% | 500 M | |
+8,04 % | 470 M | |
-.--% | 450 M |